Literature DB >> 32897163

Novel Approaches to Screening for Breast Cancer.

Ritse M Mann1, Regina Hooley1, Richard G Barr1, Linda Moy1.   

Abstract

Screening for breast cancer reduces breast cancer-related mortality and earlier detection facilitates less aggressive treatment. Unfortunately, current screening modalities are imperfect, suffering from limited sensitivity and high false-positive rates. Novel techniques in the field of breast imaging may soon play a role in breast cancer screening: digital breast tomosynthesis, contrast material-enhanced spectral mammography, US (automated three-dimensional breast US, transmission tomography, elastography, optoacoustic imaging), MRI (abbreviated and ultrafast, diffusion-weighted imaging), and molecular breast imaging. Artificial intelligence and radiomics have the potential to further improve screening strategies. Furthermore, nonimaging-based screening tests such as liquid biopsy and breathing tests may transform the screening landscape. © RSNA, 2020 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32897163     DOI: 10.1148/radiol.2020200172

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Using deep learning to safely exclude lesions with only ultrafast breast MRI to shorten acquisition and reading time.

Authors:  Xueping Jing; Mirjam Wielema; Ludo J Cornelissen; Margo van Gent; Willie M Iwema; Sunyi Zheng; Paul E Sijens; Matthijs Oudkerk; Monique D Dorrius; Peter M A van Ooijen
Journal:  Eur Radiol       Date:  2022-05-26       Impact factor: 5.315

Review 2.  Comparison of Diagnostic Test Accuracy of Cone-Beam Breast Computed Tomography and Digital Breast Tomosynthesis for Breast Cancer: A Systematic Review and Meta-Analysis Approach.

Authors:  Temitope Emmanuel Komolafe; Cheng Zhang; Oluwatosin Atinuke Olagbaju; Gang Yuan; Qiang Du; Ming Li; Jian Zheng; Xiaodong Yang
Journal:  Sensors (Basel)       Date:  2022-05-09       Impact factor: 3.847

Review 3.  Advances in breast cancer screening modalities and status of global screening programs.

Authors:  Chenyu Luo; Le Wang; Yuhan Zhang; Ming Lu; Bin Lu; Jie Cai; Hongda Chen; Min Dai
Journal:  Chronic Dis Transl Med       Date:  2022-05-25

4.  Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI).

Authors:  Ritse M Mann; Alexandra Athanasiou; Pascal A T Baltzer; Julia Camps-Herrero; Paola Clauser; Eva M Fallenberg; Gabor Forrai; Michael H Fuchsjäger; Thomas H Helbich; Fleur Killburn-Toppin; Mihai Lesaru; Pietro Panizza; Federica Pediconi; Ruud M Pijnappel; Katja Pinker; Francesco Sardanelli; Tamar Sella; Isabelle Thomassin-Naggara; Sophia Zackrisson; Fiona J Gilbert; Christiane K Kuhl
Journal:  Eur Radiol       Date:  2022-03-08       Impact factor: 7.034

Review 5.  Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements.

Authors:  Rabia Arshad; Maria Hassan Kiani; Abbas Rahdar; Saman Sargazi; Mahmood Barani; Shirin Shojaei; Muhammad Bilal; Deepak Kumar; Sadanand Pandey
Journal:  Bioengineering (Basel)       Date:  2022-07-15

Review 6.  Potential utility of miRNAs for liquid biopsy in breast cancer.

Authors:  Xiangrong Liu; Dimitri Papukashvili; Zhixiang Wang; Yan Liu; Xiaoxia Chen; Jianrong Li; Zhiyuan Li; Linjie Hu; Zheng Li; Nino Rcheulishvili; Xiaoqing Lu; Jinfeng Ma
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

Review 7.  Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.

Authors:  Fabrizia Gelardi; Elisa Maria Ragaini; Martina Sollini; Daniela Bernardi; Arturo Chiti
Journal:  Diagnostics (Basel)       Date:  2022-08-04

Review 8.  Breast Cancer-How Can Imaging Help?

Authors:  Roxana Iacob; Diana Luminita Manolescu; Emil Robert Stoicescu; Antonio Fabian; Daniel Malita; Cristian Oancea
Journal:  Healthcare (Basel)       Date:  2022-06-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.